Latest FARALLON CAPITAL MANAGEMENT LLC Stock Portfolio

FARALLON CAPITAL MANAGEMENT LLC Performance:

2025 Q4: 8.08%YTD: 15.07%2024: 16.69%

Performance for 2025 Q4 is 8.08%, and YTD is 15.07%, and 2024 is 16.69%.

About FARALLON CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings

FARALLON CAPITAL MANAGEMENT LLC is a hedge fund based in San Francisco, CA. On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, FARALLON CAPITAL MANAGEMENT LLC reported an equity portfolio of $21.2 Billions as of 31 Dec, 2025.

The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are RVMD, MSFT, AMZN. The fund has invested 5.5% of it's portfolio in REVOLUTION MEDICINES INC and 5% of portfolio in MICROSOFT CORP.

The fund managers got completely rid off AUTODESK INC (ADSK), INTUIT (INTU) and KELLANOVA (K) stocks. They significantly reduced their stock positions in TEVA PHARMACEUTICAL INDS LTD (TEVA), UNIQURE NV (QURE) and SOLENO THERAPEUTICS INC (SLNO). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in CYBERARK SOFTWARE LTD (CYBR), SYNOPSYS INC (SNPS) and BROADCOM INC (AVGO). The fund showed a lot of confidence in some stocks as they added substantially to GENEDX HOLDINGS CORP (SMFR), GUARDANT HEALTH INC (GH) and CARDINAL HEALTH INC (CAH).

FARALLON CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500

Our best estimate is that FARALLON CAPITAL MANAGEMENT LLC made a return of 8.08% in the last quarter. In trailing 12 months, it's portfolio return was 15.07%.

Performance
S&P 500

New Buys

Ticker	$ Bought
cyberark software ltd	469,719,000
synopsys inc	469,344,000
broadcom inc	308,860,000
kkr & co inc	257,216,000
dayforce inc	202,293,000
bitwise 10 crypto index etf	198,932,000
welltower inc	63,664,200
structure therapeutics inc	31,575,700

New stocks bought by FARALLON CAPITAL MANAGEMENT LLC

Additions

Ticker	% Inc.
genedx holdings corp	1,300
guardant health inc	1,262
cardinal health inc	127
tyra biosciences inc	80.69
grail inc	73.66
boston scientific corp	56.74
lantheus hldgs inc	56.09
baidu inc	51.59

Additions to existing portfolio by FARALLON CAPITAL MANAGEMENT LLC

Reductions

Ticker	% Reduced
teva pharmaceutical inds ltd	-99.2
uniqure nv	-97.52
soleno therapeutics inc	-96.73
oscar health inc	-92.75
transunion	-85.74
ishares ethereum tr	-80.12
novavax inc	-75.00
schrodinger inc	-75.00

FARALLON CAPITAL MANAGEMENT LLC reduced stake in above stock

Sold off

Ticker	$ Sold
kellanova	-323,475,000
mara holdings inc	-66,831,600
savara inc	-8,925,000
autodesk inc	-528,238,000
analog devices inc	-319,287,000
iqvia hldgs inc	-178,268,000
surgery partners inc	-18,866,400
grayscale coindesk crypto	-47,581,700

FARALLON CAPITAL MANAGEMENT LLC got rid off the above stocks

Sector Distribution

FARALLON CAPITAL MANAGEMENT LLC has about 46.3% of it's holdings in Healthcare sector.

Sector	%
Healthcare	46.3
Technology	13.9
Financial Services	12.5
Others	8.6
Consumer Cyclical	6
Industrials	5.4
Communication Services	5.4
Real Estate	1.3

Market Cap. Distribution

FARALLON CAPITAL MANAGEMENT LLC has about 76.3% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
LARGE-CAP	55.9
MEGA-CAP	20.4
MID-CAP	12.6
UNALLOCATED	8.6
SMALL-CAP	2.4

Stocks belong to which Index?

About 74.8% of the stocks held by FARALLON CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
S&P 500	50.6
Others	25.2
RUSSELL 2000	24.2

Top 5 Winners (%)		%
CAPR	capricor therapeutics inc	300.3 %
	aleanna inc	261.4 %
RVMD	revolution medicines inc	213.3 %
IRWD	ironwood pharmaceuticals inc	157.3 %
COGT	cogent biosciences inc	147.3 %

Top 5 Winners ($)		$
RVMD	revolution medicines inc	481.2 M
NTRA	natera inc	278.2 M
BBIO	bridgebio pharma inc	211.0 M
PTGX	protagonist therapeutics inc	129.0 M
LQDA	liquidia corporation	101.2 M

Top 5 Losers (%)		%
CARA	tvardi therapeutics inc	-89.0 %
BYND	beyond meat inc	-56.6 %
EVH	evolent health inc	-52.7 %
ALVO	alvotech	-37.4 %
DOCS	doximity inc	-36.1 %

Top 5 Losers ($)		$
HIMS	hims & hers health inc	-171.4 M
MSFT	microsoft corp	-70.8 M
AGIO	agios pharmaceuticals inc	-70.7 M
	ishares bitcoin trust etf	-70.1 M
	ishares ethereum tr	-40.6 M

FARALLON CAPITAL MANAGEMENT LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of FARALLON CAPITAL MANAGEMENT LLC

FARALLON CAPITAL MANAGEMENT LLC has 145 stocks in it's portfolio. About 39% of the portfolio is in top 10 stocks. HIMS proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for FARALLON CAPITAL MANAGEMENT LLC last quarter.

Last Reported on: 17 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ABC	cencora inc	0.00	1,000	337,750	unchanged	0.00

ACLX	arcellx inc	0.00	4,000	260,800	unchanged	0.00

ADI	analog devices inc	0.00	0.00	0.00	sold off	-100

ADPT	adaptive biotechnologies cor	0.00	11,000	178,640	new

ADSK	autodesk inc	0.00	0.00	0.00	sold off	-100

AGIO	agios pharmaceuticals inc	0.66	5,159,500	140,442,000	reduced	-10.75

ALE	allete inc	0.00	0.00	0.00	sold off	-100

ALKS	alkermes plc	0.00	20,800	581,984	unchanged	0.00

ALT	altimmune inc	0.00	27,600	99,636	unchanged	0.00

ALVO	alvotech	0.00	199,675	1,024,330	unchanged	0.00

AMKR	amkor technology inc	0.09	464,000	18,318,700	new

AMZN	amazon com inc	4.90	4,499,890	1,038,670,000	added	28.36

AON	aon plc	4.44	2,665,240	940,509,000	added	17.00

ARDX	ardelyx inc	0.00	23,000	134,090	unchanged	0.00

ARMK	aramark	1.63	9,357,050	344,901,000	added	4.01

ARQT	arcutis biotherapeutics inc	0.00	26,000	755,040	unchanged	0.00

ARWR	arrowhead pharmaceuticals in	0.00	15,800	1,048,960	unchanged	0.00

ASMB	assembly biosciences inc	0.20	1,227,590	41,750,300	unchanged	0.00

ASND	ascendis pharma a/s	0.00	1,400	298,536	unchanged	0.00

AVGO	broadcom inc	1.46	892,400	308,860,000	new